Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (2020) 100648]
- Resource Type
- Erratum
- Authors
- Oh, Jonathan; Barve, Minal; Senzer, Neil; Aaron, Phylicia; Manning, Luisa; Wallraven, Gladice; Bognar, Ernest; Stanbery, Laura; Horvath, Staci; Manley, Meghan; Nemunaitis, John; Walter, Adam; Rocconi, Rodney P.
- Source
- In Gynecologic Oncology Reports May 2021 36
- Subject
- Language
- ISSN
- 2352-5789